Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cells.

Key Points

• This research aims to evaluate the effects of PAK inhibition combined with PD-1 blockade on ovarian cancer treatment.
• Evaluated the efficacy of PAK inhibition alongside PD-1 blockade
• Focused on high-grade serous ovarian cancer models
• Assessed cytotoxic CD8+ T cell activation and cancer cell invasion
• PAK inhibition significantly enhanced CD8+ T cell-mediated killing of ovarian cancer cells
• The combination therapy suppressed cancer cell invasion
• Efficacy was observed in vitro, indicating potential for improved patient outcomes

Abstract